Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan offers to buy rival generic drugmaker Perrigo for $205 per share, or almost $29 billion
Mylan offers to buy rival generic drugmaker Perrigo for $205 per share, or almost $29 billion
Mylan offers to buy rival generic drugmaker Perrigo for $205 per share, or almost $29 billion
Submitted by
admin
on April 8, 2015 - 5:14pm
Source:
Yahoo/AP
News Tags:
Mylan
Perrigo
generics
M&A
Headline:
Mylan offers to buy rival generic drugmaker Perrigo for $205 per share, or almost $29 billion
Do Not Allow Advertisers to Use My Personal information
